We’re thrilled to share that Sindhu Yalavarthi has been honored with the Outstanding Junior Graduate Research Award for her pioneering work on biomedical engineering!
Artificial antigen-presenting cell can induce tailored immune response against pathogens and diseases.
MgC@PS is an efferocytosis‐inspired nanoplatform. It is a novel biotechnology recently developed in our lab to specifically target macrophages for anti-inflammatory modulation.
This award supports a collaborative pilot project to investigate engineered cells for immune regulation. We will partner with Dr. Xuewu Liu, PhD, at the Houston Methodist Research Institute to develop and evaluate a prototype engineered cell specialized for antigen presentation within the bone microenvironment. This study has the potential to yield novel therapies for bone diseases—including metastatic bone cancer—that currently lack effective treatment.
A huge congratulations to Yusif Abdul-Rashid on earning his Master’s in Nanoscience! We are thrilled that he will continue his research journey with us as a Ph.D. student in our lab. Excited to see all the great work ahead—congratulations, Yusif!
Congratulations to Sindhu Yalavarthi for having her work highlighted by UNCG! This recognition is a testament to her dedication and contributions to cutting-edge research. Well done, Sindhu—keep up the great work!
Dr. Kerui Wu was awarded the NCBiotech Flash Grant for research on synthetic antigen-presenting cells. This grant will support the continued development and exploration of cutting-edge therapeutic applications.
Congratulations to Miss. Sindhu Yalavarthi for receiving two awards at the Graduate Showcase: the Health Sciences Award and the People’s Choice Award, recognizing her outstanding research and presentation.
We are proud to announce that Miss. Sindhu Yalavarthi and Mr. Yusif Abdul-Rashid have been selected into the 2024 NNCI NTEC Cohort, where they will engage in advanced training and networking in nanotechnology.
Dr. Kerui Wu was awarded another NCBiotech Flash Grant for the research on engineered osteoclast cells, with potential applications in cancer treatment and bone health.
Dr. Kerui Wu was honored with the UNCG Internal Research Award for research on synthetic antigen-presenting cells, recognizing the impact and potential of this novel approach in immunotherapy.
We are excited to announce that Dr. Kerui Wu has been awarded the Lung Cancer Initiative Innovation Award for novel research in the treatment of lung cancer using synthetic antigen-presenting nanovesicles.
We are thrilled to announce the publication of our latest research on antigen-presenting nanovesicles in the journal Oncogene.
Dr. Kerui Wu received the competitive DOD CDMRP Lung Cancer Research Program Concept Award for the SMART_NV project, focused on developing synthetic antigen-presenting cells for lung cancer treatment.
Dr. Kerui Wu joined the Nanoscience Department at JSNN UNCG as an Assistant Professor. He will work on applying synthetic biology for both fundamental and translational aspects of life science.